IGF1 and sarcopenia: In elderly European men aged ≥70 years, low baseline IGF-1 was related to a greater reduction in gait speed; however, it is necessary to identify whether the replacement of IGF-1 is effective and safe to reverse sarcopenia in randomized controlled studies [69].